PSN-GK1 is primarily utilized in the field of biomedical research, particularly in studies focused on cancer therapy. It is known for its potential role in inhibiting specific pathways that are crucial for the survival and proliferation of cancer cells. Researchers are investigating its efficacy in targeting and disrupting these pathways, which could lead to the development of novel anti-cancer drugs. Additionally, PSN-GK1 is being explored for its ability to enhance the effectiveness of existing chemotherapy treatments, potentially reducing the required dosage and minimizing side effects. Its application extends to preclinical studies where it is used to understand the molecular mechanisms underlying tumor growth and resistance to conventional therapies. This makes PSN-GK1 a promising candidate for advancing personalized medicine approaches in oncology.